A coronavirus infection can mow down the forests of hairlike cilia that coat our airways, destroying a crucial barrier to keeping the virus from lodging deep in the lungs. Normally, those cilia move ...

In a recent study, researchers developed artificial lungs that will enhance the efficiency of respiratory disease research. A collaboration between researchers at Pohang University of Science and ...

The safety of the monoclonal antibody nirsevimab and the effect of nirsevimab on hospitalizations for respiratory syncytial virus (RSV)–associated lower respiratory tract infection when administered ...

Respiratory tract infections are common childhood illnesses. They can spread easily through the air we breathe or via our hands. You can treat most symptoms at home while the body clears the infection ...

Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infection and hospitalization in infants. Nirsevimab is a monoclonal antibody to the RSV fusion protein that has an ...